<?xml version="1.0" encoding="UTF-8"?>
<p>Improved competency for high data quality; and development of country framework/policies for data sharing are required to avoid the opacity in data sharing that was witnessed during the West Africa EVD outbreak. Also, the exportation of biological samples and data from SSA to the global North during the EVD outbreak was rampant.
 <fn id="dewb12275-note-1056">
  <label>
   <sup>56</sup>
  </label>
  <p>Woolhouse, M.E.J., Rambaut, A., Kellam, P. (2015). Lessons from Ebola: Improving infectious disease surveillance to inform outbreak management. Science Translational Medicine. 7(307): 307rv5‐rv5.</p>
 </fn> Unfortunately, there is little investment in biorepository and biobank infrastructure for ongoing and future research in SSA.
 <fn id="dewb12275-note-1057">
  <label>
   <sup>57</sup>
  </label>
  <p>Abayomi, A., Gevao, S., Conton, B., et al. (2016). African civil society initiatives to drive a biobanking, biosecurity and infrastructure development agenda in the wake of the West African Ebola outbreak. Pan African Medicine Journal. 24: 270‐270.</p>
 </fn> The limited ability to store biological samples and data during the COVID‐19 pandemic will significantly limit the conduct of future research in the region.
</p>
